Faculty

Manish Zinzuvadia

MD
Medical Director
Park Avenue Wellness Center

Dr. Zinzuvadia is the founder and director of Park Avenue Wellness Center and is board certified in both Adult and Geriatric psychiatry. He directs the psychiatric services of several residential treatment facilities while also managing a comprehensive outpatient practice in Manhattan's Upper East Side.

He received his M.D. from SUNY Downstate College of Medicine and completed his residency training in psychiatry at New York Medical College in Valhalla, NY. He completed fellowship training in geriatric psychiatry at Weill Cornell Medical College.

He has implemented programs using long acting antipsychotic injections to decrease hospital readmission rates for treatment resistant schizophrenic patients across New York. He has an expertise in treating elderly patients both in the office setting and using in-home visits. He has been able to work with families to keep patients stable and at home instead of being placed into nursing facilities.

Dr. Zinzuvadia's research and clinical interests include the use of long acting antipsychotics in treatment resistant patients, cognitive dysfunction and treatment resistant depression in older adults, and the role of novel psychopharmacological agents including ketamine infusions in treatment resistant mood disorders. He is also helping to pioneer the use of technological interventions to increase access to quality psychiatric care. He directs a program for treatment resistant depression at the Park Avenue Wellness Center using a combination of comprehensive assessment and psychopharmacology, IV Ketamine infusions, and psychotherapy.

2027 Sessions

Catching It Early, Managing It Right: Cognitive Decline and Agitation in Real-World Practice

Diagnosing dementia and managing agitation have both changed, with biomarker-based criteria and blood tests reshaping the workup and new options expanding treatment. This session covers distinguishing normal aging, MCI, and the major dementia syndromes, building a diagnostic workup, and the amyloid, tau, cholinergic, glutamatergic, and agitation neurobiology behind current therapies. Attendees will leave able to apply a stepwise approach to agitation, from reversible causes and non-pharmacologic strategies through a comparison of the FDA-approved pharmacologic options.

Speaker

Saturday, November 14 3:50–4:50 PM
Room West Side Ballroom - Salons 1 & 2
Faculty

Mark Matta

DO, DFAPA
CEO
Psych Med Associates, PC; Medical Director - People In Need & Community Alternatives, Inc.

Presently, Dr. Mark Matta completed his medical degree at the Philadelphia College of Osteopathic Medicine and went on to a residency in general adult psychiatry at Allegheny General Hospital in Pittsburgh, PA. He is a second-generation psychiatrist following his father as the CEO and Medical Director of Psych Med Associates, P.C. in New Castle, PA. He is also the medical director of People in Need and Community Alternatives, two community mental health clinics in New Castle. Chatham University has awarded Dr. Matta as the psychiatric preceptor of the year 2012 and clinical preceptor of the year in 2013. He has also been awarded Best of the Best Psychiatrist by the New Castle News from 2009-2017, 2019, 2022, 2023, and 2026 and “Elected as Distinguished Fellow” with the American Psychiatric Association in 2020.

He is the 2026-2027 president of the Pennsylvania Psychiatric Society and previously served as the president of the Pittsburgh Psychiatric Society for the 2021-2022 year and presently sits on the Lawrence County Mental Health Advisory Board. Dr. Matta was selected as one of the inaugural recipients of the Pennsylvania Medical Society’s 40 Under 40 Award.

Faculty

Rebecca Roma

MD
Chief Medical Officer, REACH, LLC; Adjunctive faculty University of Pittsburgh
REACH, LLC

Rebecca S. Roma, MD, is Chief Medical Officer at REACH, LLC, and Medical Director of the Allegheny County Residential Treatment Facility for Adults in Pittsburgh, Pennsylvania. She is board-certified in Adult Psychiatry and currently provides psychiatric evaluations, medication management, and supportive therapy for mentally ill homeless patients at the Bethlehem Haven 902 Clinic in Pittsburgh. Dr. Roma earned her medical degree at the University of Pittsburgh School of Medicine and completed her residency at the Western Psychiatric Institute and Clinic at the University of Pittsburgh Medical Center.

Dr. Roma has conducted presentations and workshops on psychotropic medications and deflecting anger and diffusing difficult situations. She also has extensive research experience and has published on the medical aspects of substance use disorders.

Faculty

Manish Zinzuvadia

MD
Medical Director
Park Avenue Wellness Center

Dr. Zinzuvadia is the founder and director of Park Avenue Wellness Center and is board certified in both Adult and Geriatric psychiatry. He directs the psychiatric services of several residential treatment facilities while also managing a comprehensive outpatient practice in Manhattan's Upper East Side.

He received his M.D. from SUNY Downstate College of Medicine and completed his residency training in psychiatry at New York Medical College in Valhalla, NY. He completed fellowship training in geriatric psychiatry at Weill Cornell Medical College.

He has implemented programs using long acting antipsychotic injections to decrease hospital readmission rates for treatment resistant schizophrenic patients across New York. He has an expertise in treating elderly patients both in the office setting and using in-home visits. He has been able to work with families to keep patients stable and at home instead of being placed into nursing facilities.

Dr. Zinzuvadia's research and clinical interests include the use of long acting antipsychotics in treatment resistant patients, cognitive dysfunction and treatment resistant depression in older adults, and the role of novel psychopharmacological agents including ketamine infusions in treatment resistant mood disorders. He is also helping to pioneer the use of technological interventions to increase access to quality psychiatric care. He directs a program for treatment resistant depression at the Park Avenue Wellness Center using a combination of comprehensive assessment and psychopharmacology, IV Ketamine infusions, and psychotherapy.

The Missing Pieces of ADHD: Practical Pearls for Clinical Practice

Attention-deficit/hyperactivity disorder (ADHD) extends beyond its classic presentation and often presents diagnostic and treatment challenges across the lifespan. This session applies DSM-5-TR criteria across the lifespan, links the underlying circuitry and catecholamine signaling to how stimulants and non-stimulants work, and distinguishes methylphenidate from amphetamine and compares the approved non-stimulants. Attendees will leave able to select and titrate treatment by age, comorbidity, and delivery system, and to describe agents approved or in development as of 2026.

Speaker

Sunday, November 15 3:50–4:50 PM
Room West Side Ballroom - Salons 1 & 2
Steering Committee

Brittany Albright

MD, MPH, DABOM
Founder and Medical Director of Multidisciplinary and Interventional Psychiatry Practice
Sweetgrass Psychiatry; Medical University of South Carolina

Brittany Albright, MD, MPH, is a Harvard-trained, triple board-certified psychiatrist with expertise in interventional psychiatry, addiction psychiatry, and obesity medicine. She completed her adult psychiatry residency at Massachusetts General Hospital and McLean Hospital, followed by fellowship training in Addiction Psychiatry at the Medical University of South Carolina (MUSC). She currently serves as an Affiliate Assistant Professor of Psychiatry at MUSC.

Dr. Albright is the Founder and CEO of Sweetgrass Psychiatry, South Carolina’s largest physician-owned psychiatry practice, with three locations and a multidisciplinary team of 25+ clinicians. A leader in advancing access to innovative care, Sweetgrass Psychiatry was the first practice to launch esketamine in South Carolina in 2019 and has since developed a comprehensive interventional psychiatry program incorporating esketamine, ketamine, long acting injectables, and transcranial magnetic stimulation.

Her academic work includes numerous abstracts presented at national meetings and peer-reviewed publications spanning innovative psychiatric treatments and medical education. A nationally recognized speaker and consultant, Dr. Albright serves as President of the South Carolina Psychiatric Association and holds multiple leadership roles with Psych Congress, including Co-Chair of Psych Congress Elevate. She also created the Private Practice Summit, a national educational program focused on advancing independent psychiatric practice.

Her clinical approach integrates psychodynamic psychotherapy, mentalization-based therapy, and motivational interviewing with evidence-based pharmacologic and interventional treatments. She enjoys treating patients across the spectrum of psychiatric illness, with particular interests in complex mood and psychotic disorders and substance use disorders. She is trained and certified in transcranial magnetic stimulation and psychedelic-assisted psychotherapy.

Faculty

Lee Cohen

MD
Associate Clinical Professor of Psychiatry
Columbia University Vagelos College of Physicians and Surgeons, N.Y.

Lee S. Cohen, MD, is an Associate Professor of Clinical Psychiatry at Columbia University Irving Medical Center, maintains a clinical practice focused on expert and complex diagnostics, and is considered an international expert in clinical psychopharmacology. He is also the director of the Clinical Neuroscience Center, LLP involved in innovative development and discovery of new compounds for neuropsychiatric conditions and directly consults with multiple pharmaceutical companies worldwide.

He is a senior reviewer for multiple journals, including the Journal of Child and Adolescent Psychopharmacology, the Journal of Developmental and Physical Disabilities, and the International Journal of Autism and Related Disabilities.
Dr Cohen teaches and presents research domestically and internationally at meetings such as the American Psychiatric Association and at Major Universities around the country. He is the recipient of the 2026 Weill Cornell Medicine/New York Presbyterian/Columbia New York-Presbyterian Child and Adolescent Psychiatry Residency Training Program-Outstanding Service Award.

Faculty

Manish Zinzuvadia

MD
Medical Director
Park Avenue Wellness Center

Dr. Zinzuvadia is the founder and director of Park Avenue Wellness Center and is board certified in both Adult and Geriatric psychiatry. He directs the psychiatric services of several residential treatment facilities while also managing a comprehensive outpatient practice in Manhattan's Upper East Side.

He received his M.D. from SUNY Downstate College of Medicine and completed his residency training in psychiatry at New York Medical College in Valhalla, NY. He completed fellowship training in geriatric psychiatry at Weill Cornell Medical College.

He has implemented programs using long acting antipsychotic injections to decrease hospital readmission rates for treatment resistant schizophrenic patients across New York. He has an expertise in treating elderly patients both in the office setting and using in-home visits. He has been able to work with families to keep patients stable and at home instead of being placed into nursing facilities.

Dr. Zinzuvadia's research and clinical interests include the use of long acting antipsychotics in treatment resistant patients, cognitive dysfunction and treatment resistant depression in older adults, and the role of novel psychopharmacological agents including ketamine infusions in treatment resistant mood disorders. He is also helping to pioneer the use of technological interventions to increase access to quality psychiatric care. He directs a program for treatment resistant depression at the Park Avenue Wellness Center using a combination of comprehensive assessment and psychopharmacology, IV Ketamine infusions, and psychotherapy.

Psychedelics in Psychiatry: Where the Science Stands and Where It's Headed

As patients and trainees increasingly ask about psychedelic and psychedelic-adjacent therapies, clinicians need a practical framework for responding. This session covers which patients are appropriate candidates and how to screen for exclusions, how the four best-studied agents are thought to work, including receptor pharmacology, desynchronization, and plasticity. Attendees will also learn to appraise the evidence, including blinding, expectancy, and effect size, and to understand each agent's regulatory status.

Speaker

Saturday, January 16 12:50–1:50 PM
Faculty

Sasidhar Gunturu

MD, DFAPA
Vice Chair | Residency Training Director
Bronx Care Health System

Dr. Sasidhar Gunturu is a distinguished psychiatrist, educator, and healthcare leader currently serving as Vice Chair for Education, Research, and Faculty Development and Director of the Psychiatry Residency Training Program at BronxCare Health System, a role he has held since June 2021.<br><br>

Dr. Gunturu completed his medical education at NTR University of Health Sciences in India before pursuing psychiatric training in the United States. He completed his General Psychiatry Residency at the Icahn School of Medicine at Mount Sinai (Bronx Lebanon Hospital), followed by a Consultation-Liaison Psychiatry Fellowship at the University of Miami Miller School of Medicine and a Public Psychiatry Fellowship at Columbia University. He is a board-certified Diplomate of the American Board of Psychiatry and Neurology and holds academic appointments as Clinical Assistant Professor of Psychiatry at Icahn School of Medicine at Mount Sinai, Clinical Associate Professor and Clerkship Site Director at St. George's University Medical School, and Adjunct Professor of Clinical Medicine and Clerkship Site Director at the American University of Antigua Medical School. <br><br>

Beyond academia, Dr. Gunturu serves as Medical Director for Psychiatric Integrated Services & Community Psychiatry at BronxCare and Consulting Chief Behavioral Health Officer at Essen Health Care, overseeing behavioral health delivery for underserved South Bronx populations. <br><br>

Nationally, Dr. Gunturu serves as President-Elect of the APA's Bronx District Branch and is a Distinguished Fellow of the American Psychiatric Association. His committee work includes the APA Council on Healthcare Systems and Financing, the APA Psychiatric Services Award Selection Committee, the Academy of Consultation-Liaison Psychiatry's Guidelines and Evidence-Based Medicine and Research Subcommittees, and the Curriculum Committee of the American Academy of Directors in Psychiatry Residency Training. Institutionally, he chairs BronxCare's Wellness Committee and serves on its Medical Executive Committee, Credentialing Committee, IRB, Ethics Committee, and GME Committee. <br><br>

An accomplished scholar, Dr. Gunturu has authored more than 50 peer-reviewed publications, delivered over 90 conference presentations, and holds editorial and peer-review roles with leading psychiatric journals. His honors include the Outstanding Resident of the Year Award from the American Psychiatric Association and the BronxCare Teacher of the Year Award. He previously served as Chief Resident in the Department of Psychiatry at the Icahn School of Medicine at Mount Sinai, an early marker of his leadership trajectory.<br><br>

Widely regarded as a mentor to emerging psychiatrists, Dr. Gunturu remains focused on research innovation, faculty development, and expanding equitable mental health access. His breadth spanning residency education, community psychiatry, and national leadership makes him an authoritative voice on the future of psychiatric training. Outside of medicine, he enjoys traveling, Scuba diving, jet skiing, and spending time with his dog.

Faculty

Manish Zinzuvadia

MD
Medical Director
Park Avenue Wellness Center

Dr. Zinzuvadia is the founder and director of Park Avenue Wellness Center and is board certified in both Adult and Geriatric psychiatry. He directs the psychiatric services of several residential treatment facilities while also managing a comprehensive outpatient practice in Manhattan's Upper East Side.

He received his M.D. from SUNY Downstate College of Medicine and completed his residency training in psychiatry at New York Medical College in Valhalla, NY. He completed fellowship training in geriatric psychiatry at Weill Cornell Medical College.

He has implemented programs using long acting antipsychotic injections to decrease hospital readmission rates for treatment resistant schizophrenic patients across New York. He has an expertise in treating elderly patients both in the office setting and using in-home visits. He has been able to work with families to keep patients stable and at home instead of being placed into nursing facilities.

Dr. Zinzuvadia's research and clinical interests include the use of long acting antipsychotics in treatment resistant patients, cognitive dysfunction and treatment resistant depression in older adults, and the role of novel psychopharmacological agents including ketamine infusions in treatment resistant mood disorders. He is also helping to pioneer the use of technological interventions to increase access to quality psychiatric care. He directs a program for treatment resistant depression at the Park Avenue Wellness Center using a combination of comprehensive assessment and psychopharmacology, IV Ketamine infusions, and psychotherapy.

The Missing Pieces of ADHD: Practical Pearls for Clinical Practice

Attention-deficit/hyperactivity disorder (ADHD) extends beyond its classic presentation and often presents diagnostic and treatment challenges across the lifespan. This session applies DSM-5-TR criteria across the lifespan, links the underlying circuitry and catecholamine signaling to how stimulants and non-stimulants work, and distinguishes methylphenidate from amphetamine and compares the approved non-stimulants. Attendees will leave able to select and titrate treatment by age, comorbidity, and delivery system, and to describe agents approved or in development as of 2026.

Speaker

Sunday, January 17 11:40–12:40 PM
Steering Committee

Brittany Albright

MD, MPH, DABOM
Founder and Medical Director of Multidisciplinary and Interventional Psychiatry Practice
Sweetgrass Psychiatry; Medical University of South Carolina

Brittany Albright, MD, MPH, is a Harvard-trained, triple board-certified psychiatrist with expertise in interventional psychiatry, addiction psychiatry, and obesity medicine. She completed her adult psychiatry residency at Massachusetts General Hospital and McLean Hospital, followed by fellowship training in Addiction Psychiatry at the Medical University of South Carolina (MUSC). She currently serves as an Affiliate Assistant Professor of Psychiatry at MUSC.

Dr. Albright is the Founder and CEO of Sweetgrass Psychiatry, South Carolina’s largest physician-owned psychiatry practice, with three locations and a multidisciplinary team of 25+ clinicians. A leader in advancing access to innovative care, Sweetgrass Psychiatry was the first practice to launch esketamine in South Carolina in 2019 and has since developed a comprehensive interventional psychiatry program incorporating esketamine, ketamine, long acting injectables, and transcranial magnetic stimulation.

Her academic work includes numerous abstracts presented at national meetings and peer-reviewed publications spanning innovative psychiatric treatments and medical education. A nationally recognized speaker and consultant, Dr. Albright serves as President of the South Carolina Psychiatric Association and holds multiple leadership roles with Psych Congress, including Co-Chair of Psych Congress Elevate. She also created the Private Practice Summit, a national educational program focused on advancing independent psychiatric practice.

Her clinical approach integrates psychodynamic psychotherapy, mentalization-based therapy, and motivational interviewing with evidence-based pharmacologic and interventional treatments. She enjoys treating patients across the spectrum of psychiatric illness, with particular interests in complex mood and psychotic disorders and substance use disorders. She is trained and certified in transcranial magnetic stimulation and psychedelic-assisted psychotherapy.

Program Chair

Ilan Melnick

MD
Chief Medical Officer, Passageway Residences of Dade County,
Passageway Residences of Dade County

Ilan Melnick, MD, is the primary psychiatrist in two outpatient clinics in the Miami, Florida area, as well as a staff psychiatrist and Chief Medical Officer at Passageway Residences of Miami-Dade County. In addition, Dr. Melnick is a staff psychiatrist and Medical Director for Jewish Community Services and performs independent medical and psychiatric evaluations for Miami-Dade County police, fire, transit and aviation departments.

Dr. Melnick received his medical degree in Bayamon, Puerto Rico and went on to do his residency in psychiatry and fellowship in geriatric psychiatry at the University of Miami/Jackson Memorial Hospital.He continues to be involved in education as an Assistant Professor at Florida International University School of medicine. He continues to be involved in education through his role giving grand rounds at major universities and hospitals around the world.

Faculty

Manish Zinzuvadia

MD
Medical Director
Park Avenue Wellness Center

Dr. Zinzuvadia is the founder and director of Park Avenue Wellness Center and is board certified in both Adult and Geriatric psychiatry. He directs the psychiatric services of several residential treatment facilities while also managing a comprehensive outpatient practice in Manhattan's Upper East Side.

He received his M.D. from SUNY Downstate College of Medicine and completed his residency training in psychiatry at New York Medical College in Valhalla, NY. He completed fellowship training in geriatric psychiatry at Weill Cornell Medical College.

He has implemented programs using long acting antipsychotic injections to decrease hospital readmission rates for treatment resistant schizophrenic patients across New York. He has an expertise in treating elderly patients both in the office setting and using in-home visits. He has been able to work with families to keep patients stable and at home instead of being placed into nursing facilities.

Dr. Zinzuvadia's research and clinical interests include the use of long acting antipsychotics in treatment resistant patients, cognitive dysfunction and treatment resistant depression in older adults, and the role of novel psychopharmacological agents including ketamine infusions in treatment resistant mood disorders. He is also helping to pioneer the use of technological interventions to increase access to quality psychiatric care. He directs a program for treatment resistant depression at the Park Avenue Wellness Center using a combination of comprehensive assessment and psychopharmacology, IV Ketamine infusions, and psychotherapy.

Bipolar Disorder: Diagnosis, Mechanism, and the Evolving Treatment Landscape

Supported by an educational grant from Johnson & Johnson.
Bipolar depression is often misdiagnosed as unipolar depression, and that error shapes everything that follows in treatment. This session applies DSM-5-TR criteria to distinguish bipolar I, bipolar II, and mixed features, connects current pathophysiology models to the pharmacology of lithium, anticonvulsants, and second-generation antipsychotics, and previews long-acting injectables and late-stage agents in development for bipolar I. Attendees will leave able to match FDA-approved treatments to acute mania, bipolar depression, or maintenance and compare agents on efficacy and tolerability.

Speaker

Sunday, January 17 3:50–4:50 PM
Steering Committee

Brittany Albright

MD, MPH, DABOM
Founder and Medical Director of Multidisciplinary and Interventional Psychiatry Practice
Sweetgrass Psychiatry; Medical University of South Carolina

Brittany Albright, MD, MPH, is a Harvard-trained, triple board-certified psychiatrist with expertise in interventional psychiatry, addiction psychiatry, and obesity medicine. She completed her adult psychiatry residency at Massachusetts General Hospital and McLean Hospital, followed by fellowship training in Addiction Psychiatry at the Medical University of South Carolina (MUSC). She currently serves as an Affiliate Assistant Professor of Psychiatry at MUSC.

Dr. Albright is the Founder and CEO of Sweetgrass Psychiatry, South Carolina’s largest physician-owned psychiatry practice, with three locations and a multidisciplinary team of 25+ clinicians. A leader in advancing access to innovative care, Sweetgrass Psychiatry was the first practice to launch esketamine in South Carolina in 2019 and has since developed a comprehensive interventional psychiatry program incorporating esketamine, ketamine, long acting injectables, and transcranial magnetic stimulation.

Her academic work includes numerous abstracts presented at national meetings and peer-reviewed publications spanning innovative psychiatric treatments and medical education. A nationally recognized speaker and consultant, Dr. Albright serves as President of the South Carolina Psychiatric Association and holds multiple leadership roles with Psych Congress, including Co-Chair of Psych Congress Elevate. She also created the Private Practice Summit, a national educational program focused on advancing independent psychiatric practice.

Her clinical approach integrates psychodynamic psychotherapy, mentalization-based therapy, and motivational interviewing with evidence-based pharmacologic and interventional treatments. She enjoys treating patients across the spectrum of psychiatric illness, with particular interests in complex mood and psychotic disorders and substance use disorders. She is trained and certified in transcranial magnetic stimulation and psychedelic-assisted psychotherapy.

Faculty

Yanko Enamorado

MD
Psychiatrist
Mount Sinai Medical Center
Faculty

Manish Zinzuvadia

MD
Medical Director
Park Avenue Wellness Center

Dr. Zinzuvadia is the founder and director of Park Avenue Wellness Center and is board certified in both Adult and Geriatric psychiatry. He directs the psychiatric services of several residential treatment facilities while also managing a comprehensive outpatient practice in Manhattan's Upper East Side.

He received his M.D. from SUNY Downstate College of Medicine and completed his residency training in psychiatry at New York Medical College in Valhalla, NY. He completed fellowship training in geriatric psychiatry at Weill Cornell Medical College.

He has implemented programs using long acting antipsychotic injections to decrease hospital readmission rates for treatment resistant schizophrenic patients across New York. He has an expertise in treating elderly patients both in the office setting and using in-home visits. He has been able to work with families to keep patients stable and at home instead of being placed into nursing facilities.

Dr. Zinzuvadia's research and clinical interests include the use of long acting antipsychotics in treatment resistant patients, cognitive dysfunction and treatment resistant depression in older adults, and the role of novel psychopharmacological agents including ketamine infusions in treatment resistant mood disorders. He is also helping to pioneer the use of technological interventions to increase access to quality psychiatric care. He directs a program for treatment resistant depression at the Park Avenue Wellness Center using a combination of comprehensive assessment and psychopharmacology, IV Ketamine infusions, and psychotherapy.

Back to top